Loading...
Loading...
India's mesalamine imports from UNITED STATES total $1.0M across 248 shipments from 15 foreign suppliers. AGRACE PHARMA leads with $345.2K in import value; the top 5 suppliers together control 52.8% of this origin. Leading Indian buyers include AJANTA PHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for mesalamine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

AGRACE PHARMA is the leading Mesalamine supplier from UNITED STATES to India, with import value of $345.2K across 19 shipments. The top 5 suppliers — AGRACE PHARMA, ESPEE BIOPHARMA & FINECHEM LLC, Espee Biopharma & Finechem LLC, AMSTERDAM PHARMA (APTEKA RX INC.), AMSTERDAM PHARMA — collectively account for 52.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AGRACE PHARMA | $345.2K | 19 | 34.2% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $65.9K | 19 | 6.5% |
| 3 | Espee Biopharma & Finechem LLC | $50.9K | 9 | 5.1% |
| 4 | AMSTERDAM PHARMA (APTEKA RX INC.) | $36.6K | 8 | 3.6% |
| 5 | AMSTERDAM PHARMA | $34.0K | 4 | 3.4% |
| 6 | SUTPHIN DRUGS INC | $27.6K | 3 | 2.7% |
| 7 | INWOOD PHARMA INC. | $27.2K | 2 | 2.7% |
| 8 | AMSTERDAM PHARMA (APTEKA RX INC) | $25.2K | 5 | 2.5% |
| 9 | AMSTERDAM PHARMA (APTEKA RX INC ) | $24.8K | 1 | 2.5% |
| 10 | SPRING BIO SOLUTION | $23.8K | 7 | 2.4% |
| 11 | GREENE-VAN PHARMACY CORP | $23.1K | 2 | 2.3% |
| 12 | Good Health Pharma Supplies | $20.7K | 4 | 2.1% |
| 13 | CHRYSALIS GROUP LLC | $18.5K | 2 | 1.8% |
| 14 | RAFF & HALL PHARMACY, | $17.5K | 8 | 1.7% |
| 15 | NEWLIFE MEDICALS (USA). INC. | $16.3K | 6 | 1.6% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED | $345.7K | 10 | 34.3% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED | $59.1K | 18 | 5.9% |
| 3 | ZYDUS LIFESCIENCES LIMITED | $57.1K | 36 | 5.7% |
| 4 | HETERO LABS LIMITED | $47.0K | 10 | 4.7% |
| 5 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $42.8K | 16 | 4.2% |
| 6 | AUROBINDO PHARMA LTD | $42.8K | 8 | 4.2% |
| 7 | USV PRIVATE LIMITED | $42.6K | 5 | 4.2% |
| 8 | MACLEODS PHARMACEUTICALS LTD | $35.9K | 6 | 3.6% |
| 9 | LAURUS LABS LIMITED | $33.7K | 6 | 3.3% |
| 10 | GLENMARK PHARMACEUTICALS LIMITED | $27.2K | 2 | 2.7% |
| 11 | LAURUS LABS PRIVATE LIMITED | $25.4K | 2 | 2.5% |
| 12 | INVENTIA HEALTHCARE LIMITED | $20.4K | 4 | 2.0% |
| 13 | ACTIMUS BIOSCIENCES PRIVATE LIMITED | $17.1K | 10 | 1.7% |
| 14 | RAPTIM RESEARCH PRIVATE LIMITED | $16.9K | 2 | 1.7% |
| 15 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $16.9K | 6 | 1.7% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Mesalamine suppliers from UNITED STATES to India include AGRACE PHARMA, ESPEE BIOPHARMA & FINECHEM LLC, Espee Biopharma & Finechem LLC. The leading supplier is AGRACE PHARMA with import value of $345.2K USD across 19 shipments. India imported Mesalamine worth $1.0M USD from UNITED STATES in total across 248 shipments.
India imported Mesalamine worth $1.0M USD from UNITED STATES across 248 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Mesalamine sourced from UNITED STATES include AJANTA PHARMA LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED. The largest buyer is AJANTA PHARMA LIMITED with $345.7K in imports across 10 shipments.
The total value of Mesalamine imports from UNITED STATES to India is $1.0M USD, across 248 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
248 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists